miR-30c suppresses prostate cancer survival by targeting the ASF/SF2 splicing factor oncoprotein

Por Huang, Ya-Qiang, Ling, Xiao-Hui, Yuan, Run-Qiang, Chen, Zhi-Yun, Yang, Sheng-Bang, Huang, Hong-Xing, Zhong, Wei-De, Qiu, Shao-Peng
Publicado no Mol Med Rep (2017)

Combined overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical recurrence-free survival in patients with prostate cancer

Por Qin, Guo-qiang, He, Hui-chan, Han, Zhao-dong, Liang, Yu-xiang, Yang, Sheng-bang, Huang, Ya-qiang, Zhou, Liang, Fu, Hao, Li, Jie-xian, Jiang, Fu-neng, Zhong, Wei-de
Publicado em 2014

An Integrative Proteomics and Interaction Network-Based Classifier for Prostate Cancer Diagnosis

Por Jiang, Fu-neng, He, Hui-chan, Zhang, Yan-qiong, Yang, Deng-Liang, Huang, Jie-Hong, Zhu, Yun-xin, Mo, Ru-jun, Chen, Guo, Yang, Sheng-bang, Chen, Yan-ru, Zhong, Wei-de, Zhou, Wen-Liang
Publicado em 2013

CC Chemokine Ligand 18 Correlates with Malignant Progression of Prostate Cancer

Por Chen, Guo, Liang, Yu-xiang, Zhu, Jian-guo, Fu, Xin, Chen, Yan-fei, Mo, Ru-jun, Zhou, Liang, Fu, Hao, Bi, Xue-cheng, He, Hui-chan, Yang, Sheng-bang, Wu, Yong-ding, Jiang, Fu-neng, Zhong, Wei-de
Publicado em 2014

Down-regulation of dual-specificity phosphatase 5 predicts poor prognosis of patients with prostate cancer

Por Cai, Chao, Chen, Jin-Yan, Han, Zhao-Dong, He, Hui-Chan, Chen, Jia-Hong, Chen, Yan-Ru, Yang, Sheng-Bang, Wu, Yong-Ding, Zeng, Yan-Ru, Zou, Jun, Liang, Yu-Xiang, Dai, Qi-Shan, Jiang, Fu-Neng, Zhong, Wei-De
Publicado no Int J Clin Exp Med (2015)

miR-195 inhibits tumor progression by targeting RPS6KB1 in human prostate cancer

Por Cai, Chao, Chen, Qing-Biao, Han, Zhao-Dong, Zhang, Yan-Qiong, He, Hui-Chan, Chen, Jia-Hong, Chen, Yan-Ru, Yang, Sheng-Bang, Wu, Yong-Ding, Zeng, Yan-Ru, Qin, Guo-Qiang, Liang, Yu-Xiang, Dai, Qi-Shan, Jiang, Fu-Neng, Wu, Shu-lin, Zeng, Guo-Hua, Zhong, Wei-De, Wu, Chin-Lee
Publicado no Clin Cancer Res (2015)